Supplements: How I Separate Evidence From Marketing

A supplement label can tell a compelling story.

It may mention a biological pathway, describe an ingredient as clinically studied, and display a long list of potential benefits.

My first question is simpler: what useful outcome has this particular intervention been shown to achieve?

Supplements can have a worthwhile role. Correcting a deficiency, addressing inadequate intake or supporting a defined goal can be clinically valuable.

The challenge is matching the claim to the evidence.

I begin with the purpose.

“Supports health” is broad. Correcting confirmed iron deficiency or helping someone meet an inadequate protein intake gives us a clearer question.

A defined purpose helps determine whether a product is appropriate, how its effect should be assessed and when its use should be reviewed.

Without that purpose, supplementation can become an expanding collection of products with no clear endpoint.

I check what was actually studied.

Evidence for an ingredient does not automatically establish evidence for every product containing it.

The formulation, dose, duration and other ingredients matter. So does the population: findings in deficient adults may not apply to people whose intake is already adequate.

“Clinically studied” should lead us towards the study details.

I distinguish mechanisms from outcomes.

An ingredient may participate in collagen formation or influence an inflammatory pathway. That can make biological sense.

But the body’s use of a nutrient does not establish that taking more improves health.

I want to know whether supplementation produced a useful outcome—and whether that outcome matters to the person considering it.

I look beyond the most impressive result.

A change in a laboratory marker may be informative. It may also leave the practical question unanswered.

For bone health, a marker of collagen formation is different from fewer fractures. For exercise support, a change in body composition is different from improved strength or independence.

Each result needs to retain its proper meaning.

I consider the whole body of evidence.

One positive study can be encouraging. Confidence grows when findings are consistent across well-designed studies and independently replicated.

I also consider limitations, including small samples, dropouts, selective outcomes and commercial involvement. Industry funding does not automatically invalidate a study, but transparency and independent confirmation matter.

I check safety and regulatory claims.

“Natural” does not remove the possibility of adverse effects or interactions. Several products can also contain the same ingredients, creating an unintended combined dose.

In Australia, an AUST L number does not mean the TGA has individually evaluated that product’s effectiveness before sale. Sponsors must hold supporting evidence. AUST L(A) products follow a different pathway that includes pre-market assessment of their efficacy claims.

Finally, I plan a review.

Before recommending a supplement, I want a clear reason to use it and a practical way to decide whether it remains worthwhile.

That includes benefit, tolerance, cost and treatment burden.

My goal is to identify where supplements offer justified value—and explain the limits clearly enough for an informed decision.

Dr D. Michael Elliott MSc DC CFMP